Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inception Therapeutics is a San Diego-based biotech discovery engine and company creation platform affiliated with Versant Ventures. Founded in 2011, the company partners with academic scientists to validate breakthrough biology, build enabling drug discovery capabilities, and launch new biotechnology companies around novel therapeutic concepts. Its in-house expertise spans chemistry, biology, and DMPK, with capabilities applied across small molecules, biologics, and nucleic acid-based approaches. Rather than advancing a single disclosed clinical pipeline under its own name, Inception functions as an incubator that generates and seeds venture-backed newcos such as Chinook Therapeutics, Lycia Therapeutics, Belharra Therapeutics, Ventus Therapeutics, Pipeline Therapeutics, Tempest Therapeutics, Adaxion Therapeutics, and Light Horse Therapeutics. The business is best understood as a platform for biotech company formation and preclinical drug discovery rather than a standalone late-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inception Discovery Engine.